| Wed, Oct 28, 2009 | | • | CytRx Announces Publication of Paper Stating that Chaperone Amplification Represents a 'Significant Strategy' in Anti-aging Pharmaceutical Design
Business Wire (Wed, Oct 28)
| | Thu, Oct 15, 2009 | | • | CYTRX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Thu, Oct 15)
| | Tue, Oct 13, 2009 | | • | CytRx Fortifies Executive Suite with Addition of Chief Medical Officer
Business Wire (Tue, Oct 13)
| | Mon, Sep 14, 2009 | | • | CytRx and Cephalon Oncology Therapies to be Evaluated as Treatment for Relapsed Acute Promyelocytic Leukemia
Business Wire (Mon, Sep 14)
| | Thu, Sep 10, 2009 | | • | CytRx Secures Key European Patent for Arimoclomol
Business Wire (Thu, Sep 10)
| | Wed, Sep 9, 2009 | | • | Correction: CytRx FDA letter
AP (Wed, Sep 9)
| | • | CytRx to Present at the Sachs Associates Annual Biotech in Europe Investor Forum
Business Wire (Wed, Sep 9)
| | • | CytRx to repsond to FDA letter in 4Q
at bizjournals.com (Wed, Sep 9)
| | Tue, Sep 8, 2009 | | • | CytRx expects to file FDA response in 4Q
AP (Tue, Sep 8)
| | • | CytRx Receives FDA Letter Regarding Arimoclomol Phase IIb Clinical Trial for ALS
Business Wire (Tue, Sep 8)
| | Fri, Sep 4, 2009 | | • | CytRx to Present at the Rodman & Renshaw Annual Healthcare Conference
Business Wire (Fri, Sep 4)
| | Mon, Aug 24, 2009 | | • | CytRx rises on preclinical data for stroke drug
AP (Mon, Aug 24)
| | • | CytRx's Arimoclomol Demonstrates Statistically Significant Cellular Evidence of Both Neuroprotection and Neuroregeneration in Animal Stroke Study
Business Wire (Mon, Aug 24)
| | Tue, Aug 18, 2009 | | • | CYTRX CORP Financials
EDGAR Online Financials (Tue, Aug 18)
| | Wed, Aug 12, 2009 | | • | CytRx's Drug Candidate INNO-206 Produces Statistically Significant Tumor Shrinkage in Animal Model of Small Cell Lung Cancer
Business Wire (Wed, Aug 12)
| | Tue, Aug 11, 2009 | | • | New Star Analyst Rankings for CytRx Corporation
StarMine (Tue, Aug 11)
| | Mon, Aug 10, 2009 | | • | CYTRX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Mon, Aug 10)
| | Fri, Aug 7, 2009 | | • | CYTRX CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Aug 7)
| | Mon, Jul 27, 2009 | | • | CYTRX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation
EDGAR Online (Mon, Jul 27)
| | Wed, Jul 8, 2009 | | • | CYTRX CORP Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Wed, Jul 8)
|
Add CYTR News to My Yahoo!:
 
| |
|
0.17% Nasdaq 
Headlines
